|

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

RECRUITINGSponsored by Chang Gung Memorial Hospital
Actively Recruiting
SponsorChang Gung Memorial Hospital
Started2025-06-09
Est. completion2028-09-30
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07248371

Summary

This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.

Eligibility

Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria:

* Individuals (male or female) aged 20 years or older
* Willing and able to provide written informed consent to participate in the study

Exclusion Criteria:

* Pregnant or breastfeeding women
* Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis
* Individuals currently undergoing active cancer treatment
* Recipients of any organ transplantation
* Patients diagnosed with dementia

Conditions7

Cardiovascular Diseases (CVD)Chronic Kidney DiseaseHealthyLiver DiseaseMetabolic Syndrome (MetS)Nonalcoholic Fatty Liver DiseaseObesity & Overweight

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.